Self Titration With Apidra to Reach Target Study (START)

PHASE4CompletedINTERVENTIONAL

Enrollment

493

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

insulin glargine

pre-filled disposable pen, in package of 5.

DRUG

Apidra (insulin glulisine)

pre-filled disposable pen, in package of 5

Trial Locations (1)

Sanofi-Aventis Administrative Office, Laval